ASCRS 2020: Assessing effectiveness of intracameral phenylephrine/ketorolac post-cataract surgeryByAlex Delaney-Gesing May 16th 2020
Dropless regimen after cataract surgery relieves patient treatment burdenByLynda ChartersMay 16th 2020
ASCRS 2020: Updates, improved injection technique from Eyepoint PharmaceuticalsByAlex Delaney-Gesing May 16th 2020
ASCRS 2020: New solutions for patient, physician access from Sun PharmaceuticalsByAlex Delaney-Gesing May 16th 2020
ASCRS 2020: Alcon research from biometer to trifocal to visualizationByAlex Delaney-Gesing May 16th 2020
ASCRS 2020: TearClear CEO shares company's vision, mission for futureByAlex Delaney-Gesing May 15th 2020
Caring for dry eye patients through the coronavirus pandemicByCynthia Matossian, MD, FACS, ABESMay 13th 2020
COVID-19 pandemic may be a ‘black swan’ event for investorsByJohn J. Grande, CFP; Traudy F. Grande, CFP; and John S. Grande, CFPMay 1st 2020
Breathing through COVID-19: First-hand account in protecting one’s health, financesByJohn J. Grande, CFP,Traudy F. Grande, CFP,John S. Grande, CFPMay 1st 2020
On the bright side .... looking for the positive amid pandemic's many negativesByPeter J. McDonnell, MDApril 26th 2020
Show me the patients: Patient satisfaction, not surgical landmarks or chart indices, mark of successByArun C. Gulani, MDApril 20th 2020
Echoes of history: COVID-19 pandemic stirs memories, tests our mettleByPeter J. McDonnell, MDApril 15th 2020
Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)ByAlex Delaney-Gesing April 14th 2020
Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)ByAlex Delaney-Gesing April 13th 2020
